Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
09/21/1999 | US5955347 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
09/21/1999 | US5955346 Variants of human prolactin and human placeatal lactogen |
09/21/1999 | US5955341 Heterodimeric receptor libraries using phagemids |
09/21/1999 | US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
09/21/1999 | US5955337 Lyase enzyme which can be used to screen fungicidal compounds |
09/21/1999 | US5955317 Antibodies to β-amyloids or their derivatives and use thereof |
09/21/1999 | US5955315 Nucleic acids encoding human interleukin-4 |
09/21/1999 | US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents |
09/21/1999 | US5955311 Monoclonal antibodies specific to VEGF receptors and uses thereof |
09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
09/21/1999 | US5955304 DivIB |
09/21/1999 | US5955303 Human chemokine receptor-like protein |
09/21/1999 | US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias |
09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
09/21/1999 | US5955293 Immunoassay by contacting sample with capture agent bound to solid support, then with monoclonal antibody, detecting presence or absence of binding |
09/21/1999 | US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents |
09/21/1999 | US5955288 Screening for ligands by transforming yeast cells which constitutively express heterologous kinase with complementary dna library, detecting intracellular protein kinase activity |
09/21/1999 | US5955284 Screening for serine protease inhibitors by using; hybridization detecting complex |
09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
09/21/1999 | US5955282 Human galactosyltransferases |
09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
09/21/1999 | US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
09/21/1999 | US5955078 Novel polypeptides and monoclonal antibodies, preparation and use to combat infection at the site of wounds, surgical implants and other in-dwelling devices such as catheters |
09/21/1999 | US5955076 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
09/21/1999 | US5955075 Molecular hybridization, genetic engineering |
09/21/1999 | US5955074 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
09/21/1999 | US5955073 Selective RNase cytotoxic reagents |
09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
09/21/1999 | CA2016841C A method for producing polymers having a preselected activity |
09/21/1999 | CA1340761C Interleukin-4-receptors |
09/20/1999 | CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.) |
09/16/1999 | WO1999046594A2 C-myc coding region determinant-binding protein (crd-bp) |
09/16/1999 | WO1999046574A2 Antibodies for assessing protein post-translational modification status and methods of making and using the same |
09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
09/16/1999 | WO1999046389A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
09/16/1999 | WO1999046386A1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5 |
09/16/1999 | WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders |
09/16/1999 | WO1999046381A2 Human fgf gene and gene expression products |
09/16/1999 | WO1999046380A2 Human membrane spanning proteins |
09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
09/16/1999 | WO1999046375A2 Human nucleic acid sequences from prostate tissue |
09/16/1999 | WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue |
09/16/1999 | WO1999046365A1 Methods and compositions for the selective expansion of gamma/delta t-cells |
09/16/1999 | WO1999046364A1 Vascular endothelial growth factor 2 |
09/16/1999 | WO1999046300A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies |
09/16/1999 | WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
09/16/1999 | WO1999046289A1 31 human secreted proteins |
09/16/1999 | WO1999046288A2 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | WO1999046278A1 Viral vector directed to predetermined target cells |
09/16/1999 | WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
09/16/1999 | WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies |
09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
09/16/1999 | WO1999045958A1 Cd154 blockade therapy for modulation of immune responses to implanted devices |
09/16/1999 | WO1999045955A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
09/16/1999 | WO1999045948A1 Reagents for detection and treatment of kaposi's sarcoma |
09/16/1999 | WO1999045903A1 Colonic delivery of protein or peptide compositions |
09/16/1999 | WO1999045777A1 Compositions and methods for treatment of asthma |
09/16/1999 | WO1999037763A3 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
09/16/1999 | WO1999036440A3 Expression of fusion proteins |
09/16/1999 | WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids |
09/16/1999 | WO1999034823A3 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
09/16/1999 | WO1999033979A3 Bone marrow secreted proteins and polynucleotides |
09/16/1999 | WO1999033522A3 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
09/16/1999 | WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use |
09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
09/16/1999 | WO1999025831A3 Slit polypeptide and method of modulation of robo with ligands |
09/16/1999 | WO1999015657A3 53bp2 complexes |
09/16/1999 | WO1999009177B1 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
09/16/1999 | WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
09/16/1999 | DE19816102C1 Inactivating viruses in protein solutions - comprises treating the protein solution with N-chlorotaurin |
09/16/1999 | DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents |
09/16/1999 | DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents |
09/16/1999 | CA2421394A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421388A1 Novel poypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421375A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421372A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421286A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421278A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2421272A1 Novel polypeptides and nucleic acids encoding the same |
09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
09/16/1999 | CA2323631A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase |
09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
09/16/1999 | CA2323210A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
09/16/1999 | CA2323074A1 Compositions and methods for the treatment and prevention of metastatic disorders |
09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
09/16/1999 | CA2323062A1 Colonic delivery of protein or peptide compositions |
09/16/1999 | CA2322771A1 Human membrane spanning proteins |
09/16/1999 | CA2322748A1 Vascular endothelial growth factor 2 |